ANNUNZIATA, PASQUALE
 Distribuzione geografica
Continente #
NA - Nord America 12.147
EU - Europa 8.153
AS - Asia 4.067
SA - Sud America 630
AF - Africa 134
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 7
Totale 25.167
Nazione #
US - Stati Uniti d'America 12.036
GB - Regno Unito 1.917
CN - Cina 1.662
IT - Italia 1.176
SG - Singapore 1.174
RU - Federazione Russa 1.162
IE - Irlanda 859
DE - Germania 822
UA - Ucraina 709
BR - Brasile 528
SE - Svezia 527
FR - Francia 483
HK - Hong Kong 317
VN - Vietnam 289
KR - Corea 225
FI - Finlandia 183
ES - Italia 133
IN - India 83
BD - Bangladesh 67
ZA - Sudafrica 61
TR - Turchia 59
CA - Canada 56
NL - Olanda 50
AR - Argentina 36
JP - Giappone 34
MX - Messico 33
PK - Pakistan 28
IQ - Iraq 25
BE - Belgio 24
AU - Australia 21
NG - Nigeria 17
PL - Polonia 16
VE - Venezuela 16
EC - Ecuador 14
ID - Indonesia 13
CI - Costa d'Avorio 11
CO - Colombia 11
RO - Romania 11
AT - Austria 10
SA - Arabia Saudita 10
CL - Cile 9
CZ - Repubblica Ceca 9
EG - Egitto 9
UZ - Uzbekistan 9
IL - Israele 8
MA - Marocco 8
NZ - Nuova Zelanda 8
DK - Danimarca 7
EU - Europa 7
JO - Giordania 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CH - Svizzera 6
KE - Kenya 6
DZ - Algeria 5
EE - Estonia 5
MY - Malesia 5
NP - Nepal 5
RS - Serbia 5
TN - Tunisia 5
AL - Albania 4
DO - Repubblica Dominicana 4
GR - Grecia 4
HR - Croazia 4
HU - Ungheria 4
KG - Kirghizistan 4
LB - Libano 4
LT - Lituania 4
UY - Uruguay 4
BH - Bahrain 3
BY - Bielorussia 3
CR - Costa Rica 3
ET - Etiopia 3
HN - Honduras 3
IR - Iran 3
PH - Filippine 3
PT - Portogallo 3
BB - Barbados 2
BO - Bolivia 2
IM - Isola di Man 2
JM - Giamaica 2
KH - Cambogia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
MM - Myanmar 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BG - Bulgaria 1
CU - Cuba 1
GM - Gambi 1
Totale 25.147
Città #
Menlo Park 2.982
Southend 1.721
Fairfield 1.016
Dallas 990
Dublin 856
Ashburn 660
Singapore 616
Jacksonville 563
Chandler 553
Woodbridge 476
Santa Clara 436
Beijing 419
Wilmington 412
Seattle 390
Ann Arbor 375
Houston 356
Cambridge 326
Hong Kong 305
Moscow 296
Hefei 278
Seoul 224
San Jose 211
Nanjing 187
Princeton 162
The Dalles 139
Milan 111
Los Angeles 110
Málaga 107
Lauterbourg 101
Siena 97
Rome 91
Boardman 90
Ho Chi Minh City 84
Hanoi 82
Nanchang 80
Dearborn 77
New York 71
San Diego 70
Helsinki 68
Buffalo 65
Johannesburg 50
Izmir 40
San Mateo 40
São Paulo 40
Kunming 39
Norwalk 39
Shenyang 38
Florence 36
London 36
Hebei 35
San Francisco 34
Tianjin 32
Council Bluffs 30
Columbus 27
Tokyo 27
Bengaluru 25
Jiaxing 25
Changsha 23
Munich 23
Brussels 22
Naples 22
Shanghai 22
Turin 22
Bologna 20
Jinan 20
Orem 20
Rio de Janeiro 20
Toronto 20
Düsseldorf 19
Chicago 18
Palermo 18
Venezia 18
Atlanta 17
Redondo Beach 17
Abuja 15
Ottawa 15
Phoenix 14
Bari 13
Chennai 13
Genoa 13
Guangzhou 13
Hangzhou 13
Baghdad 12
Brasília 12
Dhaka 12
Zhengzhou 12
Abidjan 11
Amsterdam 11
Haiphong 11
Madrid 11
Nuremberg 11
Redwood City 11
Stockholm 11
Curitiba 10
Falls Church 10
Fucecchio 10
Montreal 10
Ningbo 10
Warsaw 10
Cagliari 9
Totale 17.490
Nome #
Meningoencefalite da Listeria e sindrome di Miller-Fisher: un’inusuale associazione 745
Sclerosi multipla e sindrome di Sjogren . Più di una semplice associazione? 699
A case of bilateral facial palsy with detection of herpes simplex virus type 1 DNA in the cerebrospinal fluid and serum anti-gm1 antibodies. 370
Listeria meningoencephalitis and anti-GQ1b antibody syndrome 343
Altered CSF protein pattern in a case of mycosis fungoides with nervous system involvement 338
Severe aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder with short myelitis lesion and favourable outcome 307
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project" 305
Transient supranuclear paresis of the abduction in viral encephalitis of the brainstem 303
Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing-remitting multiple sclerosis 303
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 299
Substance P antagonist blocks leakage and reduces activation of cytokine-stimulated rat brain endothelium 297
Sjögren's syndrome and multiple sclerosis: Two sides of the same coin? 271
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study) 267
Sindrome di Vogt-Koyanagi-Harada e gestazione. 266
Demyelinating polyneuropathy in a case of anti-LGI1 encephalitis 266
ANTIBODIES DIRECTED AGAINST THE MYELIN BASIC PROTEIN RECOGNISING AN EPITOPE OF CD64 AND THEIR USE AS IMMUNOSUPPRESSANT 261
A difficult case: sarcoidosis with CNS involvement or sarcoidosis associated with multiple sclerosis? 261
Postpartum relapses increase the risk of disability progression in multiple sclerosis: The role of disease modifying drugs 260
Successful response of non-recovering Ramsay Hunt syndrome to intravenous high dose methylprednisolone 256
Association of anti-GM1 antibodies but not of anti-cytomegalovirus, Campylobacter jejuni and Helicobacter pylori IgG, with a poor outcome in Guillain-Barré syndrome 255
Circulating gp120 alters the blood-brain barrier permeability in HIV-1 gp120 transgenic mice 249
Impairment of vertical saccades from an acute pontine lesion in multiple sclerosis 249
Expression of tight junction and drug efflux transporter proteins in an in vitro model of human blood-brain barrier 249
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 249
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 245
Expression of preprotachykinin-A mRNA isoforms and substance P production in T lymphocytes of human healthy subjects 243
Serum anti-brain endothelium antibodies and cognitive assessment in patients with Binswanger's encephalopathy 241
Autoimmunitary changes in adrenoleukodystrophy and adrenomyeloneuropathy 239
Anti-HTLV-I antibodies in the serum and CSF from amyotrophic lateral sclerosis patients: negative findings 238
Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy 236
Adrenomyeloneurodystrophy with late cerebral involvement and evidence of a multiple autoimmune disorder 230
Serum beta-2 microglobulin levels and cognitive function in chronic dialysis patients 228
Clinical-radiologic heterogeneity of occipital neuralgiform pain as multiple sclerosis relapse. 227
Neuroinflammation and neuroprotection: an update on (future) neurotrophin-related strategies in multiple sclerosis treatment 227
A novel highly selective cannabinoid CB2 agonist reduces in vitro growth and TGF-beta release of human glial cell tumors 227
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis 226
Symptomatic cranial neuralgias in multiple sclerosis: Clinical features and treatment 226
Serotonin levels and depression in patients with multiple sclerosis 224
Behçet's disease: an unusual case with bilateral obliterating retinal panarteritis and ischemic optic atrophy 224
Cytokine production from peripheral mononuclear cells in 2 patients affected by adrenomyeloneuropathy 223
Lymphocyte activating factor activity in the serum and cerebrospinal fluid of patients with multiple sclerosis 221
Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis 220
Miller-Fisher syndrome following vaccination against influenza virus A/H1N1 in an AIDS patient 219
Nimodipine confers clinical improvement in two models of experimental autoimmune encephalomyelitis 218
High frequency of psoriasis in relatives is associated with early onset in an Italian multiple sclerosis cohort 217
Adrenoleukodystrophy: a genetic, clinical, biochemical and computed tomographic study of four patients in three different families 216
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta. 215
The potential role of hepatitis C virus in the pathogenesis of the neurological syndrome in chronic hepatitis C 213
Clinical features of Sjogren’s syndrome in patients with multiple sclerosis 213
Early synthesis and correlation of serum anti-thyroid antibodies with clinical parameters in multiple sclerosis 213
VII Congress of the Italian Neuroimmunology Group 207
Long time interval between multiple sclerosis onset and occurrence of primary Sjogren's syndrome in a woman treated with interferon-beta 206
Idiopathic bilateral facial palsy: is a causative role of anti-GM1 ganglioside and herpes simplex type 1 possible? 203
Higher expression of BDNF receptor gp145trkB is associated with lower apoptosis intensity in T cell lines in multiple sclerosis 202
Reply to :" Miller Fisher syndrome following vaccination" 199
Impairment of human brain development: glycoconjugate and lipid changes in congenital athyroidism 197
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks 197
Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy 195
L'endotelio cerebrale: ruolo nell'immunità. 195
High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients 194
Development of cerebellar cells in neuron enriched cultures: cell surface proteins 192
Aspetti biologici dell'interleukina-1. 192
Increase of predominantly k-type light chains in the CSF of a case of subacute sclerosing panencephalitis treated with interferon 190
Aggiornamenti sull'eziopatogenesi della Sclerosi multipla. 188
Supportive strategies to improve adherence to IFN β-1b in multiple sclerosis - Results of the βPlus observational cohort study 187
Multiple sclerosis onset after antitetanus toxoid immunoglobulin prophylaxis 186
Alcune evidenze per un possibile ruolo del sistema immunitario nella patogenesi della Sclerosi laterale amiotrofica. 186
Registro toscano e sclerosi multipla: dati preliminari 186
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks 186
Cerebrospinal fluid immunoglobulins and neurologic diseases [Immunoglobuline liquorali e malattie neurologiche] 186
The prevalence of pain in multiple sclerosis. A multicenter cross-sectional study 186
null 186
IL-6 detection in multiple sclerosis brain 184
Stability of lysosomal enzyme activity in post-mortem rat brain 183
HIV-1 gp 120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance p 183
Les glycoconjuguées de membranes dans la maladie de Creutzfeldt-Jakob. 182
Breastfeeding is not related to postpartum relapses in multiple sclerosis 180
Association of serum polyclonal anti-GM1 IgM and anti-neurofilament antibodies with CSF oligoclonal bands in a young with amyotrophic lateral sclerosis 179
Serum fractions from amyotrophic lateral sclerosis patients depress voltage-activated Ca2+ of rat cerebellar granule cells in culture 179
Acute transverse myelitis and hepatitis C virus 178
Congenital metachromatic leucodystrophy with severe and persistent muscular hypotonia [Leucodistrofia metacromatica congenita con grave e persistente ipotonia muscolare] 178
Brain glycosidases in Creutzfeldt-Jakob disease 178
Effect of aging on the heterosaccharide moiety of glycoproteins: study of concanavalin A-bound glycoproteins and glycosidases 177
Cerebrospinal fluid markers of demyelination: MBP and anti-brain protein antibodies. 177
Enhanced secretion of substance P by cytokine-stimulated rat brain endothelium cultures 176
Neurochemical changes in Creutzfeldt-Jakob disease 176
Adult dementia in three siblings: ceroid-lipofuscinosis 176
Meaningful improvement in walking performance after botulinum neurotoxin A (BoNT-A) in chronic spastic patients 176
Study of influence of sex and age on human normal serum lysosomal enzymes by using 4-methylumbelliferyl substrates 176
Intrathecal synthesis of anti-myelin basic protein IgG in HIV-1+ patients 173
Certain surface properties of isolated and cultured cerebellar cells. 173
Frequency of blood-retina and blood-brain barrier changes in multiple sclerosis 173
Consensus recommendations of the Italian Association for Neuroimmunology for immunochemical cerebrospinal fluid examination 172
Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice 167
Lessons from the "Euro-Lupus Cohort" 166
Complement alterations in the CSF of patients with amyotrophic lateral sclerosis 163
Detection of Borrelia burgdoferi DNA and complement attack complex deposits in the sural nerve of a patient with chronic polyneuropathy and tertiary Lyme disease 162
High levels of cerebrospinal fluid IgM binding to myelin basic protein are associated with early benign course in multiple sclerosis 159
Established and emerging features of brain vessel inflammation 157
Glycosaminoglycan and glycoprotein changes in subacute sclerosing leucoencephalitis 155
Totale 22.641
Categoria #
all - tutte 69.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021113 0 0 0 0 0 0 0 0 0 0 0 113
2021/20221.291 92 185 54 100 47 43 76 53 63 166 143 269
2022/20232.309 138 129 280 308 245 456 56 183 235 133 104 42
2023/20241.380 63 44 116 50 73 332 426 46 12 39 51 128
2024/20252.890 73 163 238 157 397 141 69 142 240 115 309 846
2025/20265.717 567 1.081 622 596 1.031 241 703 186 172 269 118 131
Totale 25.265